Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer ; volume:18 ; number:1 ; day:27 ; month:12 ; year:2018 ; pages:1-11 ; date:12.2018
BMC cancer ; 18, Heft 1 (27.12.2018), 1-11, 12.2018
- Creator
-
McGuire, William P.
Penson, Richard T.
Gore, Martin
Herraez, Antonio Casado
Peterson, Patrick
Shahir, Ashwin
Ilaria, Robert
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-5198-4
- URN
-
urn:nbn:de:101:1-2019021416332142151202
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McGuire, William P.
- Penson, Richard T.
- Gore, Martin
- Herraez, Antonio Casado
- Peterson, Patrick
- Shahir, Ashwin
- Ilaria, Robert
- SpringerLink (Online service)
Other Objects (12)
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment